Even A Likely FDA Approval For A Rare Disorder May Not Meaningfully Move The Needle For This Biotech Stock

A biotech stock with strong FDA approval odds this November may see limited upside amid a full valuation and a pending lawsuit.

Semaglutide showdown: Pills or shots—Which is right for you?

This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key ...

Does America's New Favorite Anxiety Drug Have a Dark Side?

Gabapentin has become the 5th most prescribed drug. It's also getting a bad reputation. Here's why it doesn't deserve it, ...

Can enclomiphene for low testosterone cause hair loss?

This article was reviewed by Felix Gussone, MD. Does Enclomiphene Cause Hair Loss? Enclomiphene citrate, an investigational medication that has gained attention for its potential as ...

Eli Lilly says weight-loss pill a candidate for speedy approval under new US program

Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...

FDA approves pill which can prevent heart attack, stroke by reducing inflammation: How it works

The FDA has approved Rybelsus, the first oral GLP-1 receptor agonist, for managing cardiovascular risks in adults. This ...